YI sentiment intelligence

111 Inc Company Profile & Introduction

This article provides a company profile and introduction for 111 Inc. It outlines key information about the company's business and operations.

Tone

Neutral 50/100

Event

Market update

Published

08 Jul 2026 11:10

Source

Moomoo

111 Inc. (YI) Slips 4.4% as Stock Tests Key Support Near $3.92 - Fade Trade

Tone

Neutral 50/100

Event

Market update

Published

06 Jul 2026 02:32

Source

dars.gov.et

111 Inc. (YI) Slips 4.4% as Stock Tests Key Support Near $3.92 - MA Crossover

Tone

Neutral 50/100

Event

Market update

Published

05 Jul 2026 07:00

Source

DonanımHaber

111 Inc Friday sector check, YI shares track China healthcare peers

This article provides an update on 111 Inc (YI), a China-based online pharmacy and healthcare platform, noting its close ties to the country's digital healthcare sector. With no new company filings, the focus shifts to peer performance, sector dynamics, and 111 Inc's positioning

Tone

Neutral 50/100

Event

Market update

Published

27 Jun 2026 07:40

Source

AD HOC NEWS

Price to earnings forward of 111, Inc. – NASDAQ:YI

The article provides a financial snapshot for 111, Inc. (NASDAQ:YI) on TradingView, focusing on its price-to-earnings forward metric. It indicates that the market was closed at the time the information was accessed, with no trades reported. The content also briefly touches upon v

Tone

Neutral 50/100

Event

Earnings

Published

26 Jun 2026 09:39

Source

TradingView

Enterprise value to EBIT forward of 111, Inc. – NASDAQ:YI

This article provides financial information for 111, Inc. (NASDAQ: YI), specifically its enterprise value to EBIT forward. It indicates the stock market for YI is currently closed with no trades. The content also notes various data providers for the financial information presente

Tone

Neutral 50/100

Event

Market update

Published

25 Jun 2026 16:11

Source

TradingView

111, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:YI)

This page from TradingView provides financial actuals and estimates for 111, Inc. Sponsored ADR (NASDAQ: YI). It allows users to explore reported financial data and analyst estimates across various financial statements, compare actual results with estimates, and visualize trends

Tone

Neutral 50/100

Event

Earnings

Published

25 Jun 2026 15:11

Source

TradingView

Enterprise value to EBITDA forward of 111, Inc. – NASDAQ:YI

The article focuses on the enterprise value to EBITDA forward for 111, Inc. (NASDAQ: YI) as presented on TradingView. It highlights financial data and market information specific to the company's stock performance. The content appears to be a financial snapshot from a trading pla

Tone

Neutral 50/100

Event

Market update

Published

25 Jun 2026 11:10

Source

TradingView

Enterprise value to revenue forward of 111, Inc. – NASDAQ:YI

This article focuses on the enterprise value to revenue forward metric for 111, Inc. (NASDAQ: YI). It appears to be a financial data point provided by TradingView, indicating a specific financial ratio for the company. The content primarily lists navigation elements and disclaime

Tone

Neutral 50/100

Event

Earnings

Published

25 Jun 2026 04:10

Source

TradingView

Price to book forward of 111, Inc. – NASDAQ:YI

This article provides financial information for 111, Inc. (NASDAQ: YI), specifically focusing on its price to book forward metric. It indicates that the market was closed with no trades at the time of publication. The content also lists various features and services offered by Tr

Tone

Neutral 50/100

Event

Market update

Published

24 Jun 2026 19:10

Source

TradingView

111 Inc | 4: Statement of changes in beneficial ownership of securities-Director Sun Jian David

This article reports on a Statement of Changes in Beneficial Ownership of Securities (Form 4) for Director Sun Jian David of 111 Inc. This form is filed with the SEC to disclose transactions involving the company's securities by insiders.

Tone

Neutral 50/100

Event

Market update

Published

19 Jun 2026 05:11

Source

Moomoo

111 Inc (YI) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of 111 Inc (YI), noting its current valuation score of 9.73, which ranks 7th out of 157 in the Pharmaceuticals industry. It highlights the company's current P/E ratio of -40.42, which is significantly lower than its recent high and highe

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 03:10

Source

TradingKey

111 Inc (YI) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast summary for 111 Inc (YI), noting that no earnings forecast score is currently available for the company, while the Pharmaceuticals industry average is 7.84. It highlights that relevant data for financial forecasting in terms of EPS, Reve

Tone

Neutral 50/100

Event

Earnings

Published

18 Jun 2026 03:10

Source

TradingKey

111 Inc (YI) Institutional Confidence

The article details the institutional confidence score for 111 Inc (YI), placing it 94th out of 157 in the Pharmaceuticals industry. It highlights a significant 446.56% quarter-over-quarter increase in institutional shareholding proportion to 6.89%. The largest institutional shar

Tone

Neutral 50/100

Event

Market update

Published

18 Jun 2026 02:40

Source

TradingKey

111 Inc (YI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for 111 Inc (YI), detailing its business segments and their respective contributions. As of the last update on April 6, the company's revenue is predominantly generated from Product Revenues at 99.44% ($2.98 B), with Service Revenues cont

Tone

Neutral 50/100

Event

Earnings

Published

17 Jun 2026 19:09

Source

TradingKey